Evidence map›Paper›PMID 39781207›Full record

ArticleComputers & chemical engineering2025

Rapid Design of Combination Antimicrobial Therapy against

Brianna M Eales, James Smith, Nazanin Pouya, Cole S Hudson, Vincent H Tam, Michael Nikolaou

Abstract read
In one paragraph

Article in Computers & chemical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brianna M EalesDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204.
James SmithDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204.
Nazanin PouyaDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204.
Cole S HudsonDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204.
Vincent H TamDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204.
Michael NikolaouDepartment of Chemical and Biomolecular Engineering, University of Houston Cullen College of Engineering, Houston, TX 77204.

Funding

Personalized Antimicrobial Combinations to Combat ResistanceR01AI140287 · NIAID · UNIVERSITY OF HOUSTON · PI VINCENT H TAM · 2018 to 2026
$5.9M
NIAID NIH HHS R01 AI140287
6 · The paper itself

Abstract

Treatment of serious bacterial infections with antimicrobial agents, such as antibiotics, is a major clinical challenge, because of growing bacterial resistance to multiple agents. Combination therapy (i.e. combined dosing of more than one agent) is often used for the purpose, but its systematic design remains a challenge. To address this, we recently reported a method to mathematically model bacterial response to antimicrobial agents, and to use this model for systematic design of clinically relevant combination therapy. The method relies on (a) longitudinal data of bacterial load, estimated from optical density measurements during time-kill experiments in an automated instrument, and (b) use of these data to fit a mathematical model for combination therapy design. In this work, we studied an application of the proposed method to (a) an important bacterial pathogen (

Identifiers

PMID39781207
PMCPMC11709450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.